Etodolac description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Etodolac

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

Cardiovascular Risk
  • ●      NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction (MI), and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk. (SeeWARNINGS).
  • ●     Etodolac capsules USP, 200 mg and 300 mg, and Etodolac tablets USP, 400 mg and 500 mg are contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery (SeeWARNINGS).

Gastrointestinal Risk
  • ●      NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal (GI) events. (SeeWARNINGS).

ETODOLAC DESCRIPTION



Etodolac




CLINICAL PHARMACOLOGY


PHARMACODYNAMICS




PHARMACOKINETICS

Absorption
Table 1

*
PK ParametersNormal Healthy Adults (18-65)Healthy Males (18-65)Healthy Females (27-65)Elderly (>65) (70-84)Hemodialysis (24-65) (n=9) Dialysis Renal Impairment (46-73)Hepatic Impairment (34-60)(n=179)(n=176)(n=3)Dialysis OnDialysis Off(n=10)(n=9)**
Distribution


Metabolism


Excretion




Special Populations

Geriatric
PRECAUTIONS, Geriatric Use
WARNINGS, Renal Effects

Pediatric


Race


Hepatic Insufficiency


Renal Insufficiency

CLINICAL TRIALS

Analgesia


Osteoarthritis


Rheumatoid Arthritis


INDICATIONS & USAGE

WARNINGS

  • ●     For acute and long-term use in the management of signs and symptoms of the following:


  • ●     For the management of acute pain

ETODOLAC CONTRAINDICATIONS


WARNINGS, Anaphylactoid ReactionsPRECAUTIONS, Pre-existing Asthma
WARNINGS

WARNINGS

CARDIOVASCULAR EFFECTS

Cardiovascular Thrombotic Events

WARNINGS, Gastrointestinal Effects - Risk of Ulceration, Bleeding, and Perforation
CONTRAINDICATIONS

Hypertension


Congestive Heart Failure and Edema


Gastrointestinal Effects - Risk of Ulceration, Bleeding, and Perforation




Renal Effects




Advanced Renal Disease


Anaphylactoid Reactions
CONTRAINDICATIONSPRECAUTIONS, General, Pre-existing Asthma

Skin Reactions


Pregnancy
PRECAUTIONS, Pregnancy, Nonteratogenic Effects

PRECAUTIONS

General



Hepatic Effects



Hematological Effects



Pre-existing Asthma


INFORMATION FOR PATIENTS


WARNINGS, Cardiovascular Effects
WARNINGS, Gastrointestinal Effects - Risk of Ulceration, Bleeding, and Perforation



WARNINGS


LABORATORY TESTS



DRUG INTERACTIONS

ACE-inhibitors
WARNINGS

Antacids


Aspirin


Cyclosporine, Digoxin, Methotrexate


Diuretics
WARNINGS, Renal Effects

Glyburide


Lithium


Phenylbutazone


Phenytoin


Warfarin


DRUG & OR LABORATORY TEST INTERACTIONS




CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY



PREGNANCY

Teratogenic Effects-Pregnancy Category C


Nonteratogenic Effects


LABOR & DELIVERY



NURSING MOTHERS



PEDIATRIC USE



GERIATRIC USE

WARNINGS
CLINICAL PHARMACOLOGY, Special Populations
WARNINGS
WARNINGS, Renal Effects

ETODOLAC ADVERSE REACTIONS







Incidence Greater Than Or Equal To 1% - Probably Causally Related

1111
11






1


Incidence Less Than 1% - Probably Causally Related












Incidence Less Than 1% - Causal Relationship Unknown












Additional Adverse Reactions Reported with NSAIDs








OVERDOSAGE




DOSAGE & ADMINISTRATION

WARNINGS

WARNINGS, Renal Effects

Analgesia


Osteoarthritis and Rheumatoid Arthritis



HOW SUPPLIED


















SPL MEDGUIDE




  • ●     with longer use of NSAID medicines
  • ●     in people who have heart disease


  • ●     can happen without warning symptoms
  • ●     may cause death     

  • ●               taking medicines called "corticosteroids" and "anticoagulants"
  • ●               longer use
  • ●               smoking
  • ●               drinking alcohol
  • ●               older age
  • ●               having poor health

  • ●     exactly as prescribed
  • ●     at the lowest dose possible for your treatment
  • ●     for the shortest time needed


  • ●     different types of arthritis
  • ●     menstrual cramps and other types of short-term pain


  • ●     if you had an asthma attack, hives, or other allergic reaction with aspirin or any other NSAID medicine
  • ●     for pain right before or after heart bypass surgery

  • ●     about all of your medical conditions.
  • ●     about all of the medicines you take. NSAIDs and some other medicines can interact with each other and cause serious side effects. Keep a list of your medicines to show to your healthcare provider and pharmacist.
  • ●     if you are pregnant. NSAID medicines should not be used by pregnant women late in their pregnancy.
  • ●     if you are breastfeeding. Talk to your doctor.





  • ●     Aspirin is an NSAID medicine but it does not increase the chance of a heart attack. Aspirin can cause bleeding in the brain, stomach, and intestines. Aspirin can also cause ulcers in the stomach and intestines.
  • ●     Some of these NSAID medicines are sold in lower doses without a prescription (overthecounter). Talk to your healthcare provider before using overthecounter NSAIDs for more than 10 days.

Generic NameTradename* *








PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Etodolac

Etodolac

Etodolac

Etodolac CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-331(NDC:51672-4017)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
ETODOLAC ETODOLAC 300 mg

Inactive Ingredients

Ingredient Name Strength
GELATIN
ISOPROPYL ALCOHOL
SILICON DIOXIDE
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline
propylene glycol
povidone
water
SHELLAC
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
pink 22 mm ETO;300;MG CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-331-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075078 2011-06-27


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.